ProShare Advisors’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2018
Q1 | – | Sell |
-35,570
| Closed | -$638K | – | 1806 |
|
|
2017
Q4 | $638K | Buy |
35,570
+7,199
| +25% | +$129K | ﹤0.01% | 1015 |
|
|
2017
Q3 | $335K | Buy |
28,371
+2,011
| +8% | +$23.7K | ﹤0.01% | 1101 |
|
|
2017
Q2 | $277K | Sell |
26,360
-1,378
| -5% | -$14.5K | ﹤0.01% | 1207 |
|
|
2017
Q1 | $305K | Sell |
27,738
-6,306
| -19% | -$69.3K | ﹤0.01% | 1242 |
|
|
2016
Q4 | $461K | Buy |
34,044
+2,833
| +9% | +$38.4K | 0.01% | 1115 |
|
|
2016
Q3 | $384K | Sell |
31,211
-5,743
| -16% | -$70.7K | 0.01% | 1056 |
|
|
2016
Q2 | $405K | Buy |
36,954
+369
| +1% | +$4.04K | 0.01% | 1058 |
|
|
2016
Q1 | $400K | Sell |
36,585
-3,478
| -9% | -$38K | 0.01% | 1089 |
|
|
2015
Q4 | $693K | Buy |
40,063
+3,184
| +9% | +$55.1K | 0.01% | 890 |
|
|
2015
Q3 | $733K | Sell |
36,879
-2,340
| -6% | -$46.5K | 0.01% | 779 |
|
|
2015
Q2 | $644K | Sell |
39,219
-320
| -0.8% | -$5.26K | 0.01% | 981 |
|
|
2015
Q1 | $615K | Buy |
39,539
+6,360
| +19% | +$98.9K | 0.01% | 1080 |
|
|
2014
Q4 | $474K | Buy |
33,179
+3,310
| +11% | +$47.3K | 0.01% | 1230 |
|
|
2014
Q3 | $194K | Sell |
29,869
-5,642
| -16% | -$36.6K | ﹤0.01% | 1989 |
|
|
2014
Q2 | $245K | Sell |
35,511
-10,882
| -23% | -$75.1K | ﹤0.01% | 2050 |
|
|
2014
Q1 | $332K | Buy |
46,393
+26,756
| +136% | +$191K | ﹤0.01% | 2179 |
|
|
2013
Q4 | $185K | Sell |
19,637
-3,932
| -17% | -$37K | ﹤0.01% | 1264 |
|
|
2013
Q3 | $147K | Buy |
23,569
+8,508
| +56% | +$53.1K | ﹤0.01% | 2301 |
|
|
2013
Q2 | $99K | Buy |
+15,061
| New | +$99K | ﹤0.01% | 2259 |
|